OAC
SGMT icon

OMERS Administration Corp’s Sagimet Biosciences SGMT Stock Holding History

OMERS Administration Corp’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
41,100
-12,300
-23% -$68.6K ﹤0.01% 901
2025
Q4 		$316K Buy
+53,400
New +$384K ﹤0.01% 798
2025
Q2 		– Sell
-85,600
Closed -$279K – 1072
2025
Q1 		$279K Buy
85,600
+27,100
+46% +$114K ﹤0.01% 872
2024
Q4 		$263K Buy
+58,500
New +$296K ﹤0.01% 840

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OMERS Administration Corp's SGMT Position: Q1 2026 in Review

OMERS Administration Corp reduced its Sagimet Biosciences (SGMT) stake by 23% in Q1 2026, selling an estimated $68.6K and leaving 41,100 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

OMERS Administration Corp first reported a position in SGMT in Q4 2024 and has held it in 4 quarters since. The position peaked at $316K in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • OMERS Administration Corp held 41,100 shares of Sagimet Biosciences worth $215K as of Q1 2026.
  • OMERS Administration Corp sold 12,300 Sagimet Biosciences shares in Q1 2026, an estimated $68.6K.
  • Sagimet Biosciences made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #901 holding.
  • OMERS Administration Corp first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 4 quarters since.
  • OMERS Administration Corp's Sagimet Biosciences position peaked at $316K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.